Litifilimab, CAS 2407378-48-5

Product Description: Litifilimab is a humanized IgG1-κ antibody targeting to C-type lectin domain family 4 member C (CLEC4C). Litifilimab can be used for cutaneous lupus erythematosus (CLE) study[1][2].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Litifilimab. IMGT/mAb-DB./[2]Cho SK, et al. Litifilimab (BIIB059), a promising investigational drug for cutaneous lupus erythematosus. Expert Opin Investig Drugs. 2023 May;32(5):345-353.

CAS Number: 2407378-48-5

Molecular Weight: N/A

Compound Purity: 99.42

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO/H2O

Target: Others

• Artikelnummer: MEXHY-P9990-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P9990-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated